Based on these reports, we explored whether some cancer cells of non-endothelial origin, including glioma as well as osteosarcoma SAOS2, acquire de novo transcription of the VWF gene and determined the functional consequences with regard to tumor cell adhesion and extravasation. The gene discussed is VWF; the disease is glioma.